At Ind-Swift Group, our business model at the Samba plant is designed to cater to both domestic and global markets through a value-centric and collaborative approach. We strengthen India’s healthcare network through ethical marketing, while our export vertical thrives on strategic partnerships, dossier licensing, and contract manufacturing.
Located in SIDCO Industrial Area, Samba (Jammu & Kashmir), this compact yet highly efficient manufacturing unit spans 24 kanals and is designed to deliver quality-driven pharmaceutical products with speed and precision.
The facility manufactures a diverse range of dosage forms including tablets, capsules, dry syrups and ointments tubes. We not only produce under our own brand portfolio but also engage in technical collaborations and manufacture products for other pharmaceutical companies, meeting varied market needs with flexibility and compliance. Built as per current Good Manufacturing Practices (cGMP), the unit integrates modern machinery and strong quality assurance systems to meet all compliance standards.
Its strategic location supports seamless logistics and distribution across key markets. With its focused capacity and compliance-driven processes, the Samba unit stands as a vital part of Ind-Swift’s manufacturing ecosystem — committed to delivering safe, affordable, and effective healthcare solutions.
